Constellium Cost Pressures Reinforce Cautious Stance

What happened

Constellium's Q1 2026 cost of sales surged 19% to $2.04B on elevated aluminum prices and input costs, pressuring already thin margins. The company's high leverage (Net Debt/EBITDA 3.3x) and weak interest coverage (0.23x) leave little buffer against cost inflation. While Constellium benefits from secular tailwinds in aerospace and recycling, its ability to pass through costs is limited, as seen in volatile quarterly earnings. The stock's 58% rally over the past year to ~21x P/E already prices in a cyclical recovery, but the cost headwinds raise doubts about sustainable free cash flow. The latest data reinforces the deep value report's 'WAIT' stance, as margin pressure combined with balance sheet fragility suggests limited upside for new capital.

Implication

The cost pressure signals that Constellium's recovery may be slower than anticipated. With high leverage, any sustained margin squeeze could lead to covenant issues or equity dilution. The stock's valuation leaves no room for error. Investors should wait for evidence of sustainable FCF and deleveraging before entering. The secular growth story is intact, but financial risks dominate near-term.

Thesis delta

The news of rising cost pressures does not alter the overall thesis of a wait-and-see stance, but it adds near-term risk to margin recovery expectations. If cost inflation persists, the anticipated earnings recovery may be delayed, increasing the probability of a sell-off. The core thesis remains that CSTM is a structurally leveraged cyclical with limited upside at current multiples until FCF improves.